Recombinant multi-species Syntenin 2/SDCBP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntenin 2/SDCBP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene contains two class II PDZ domains. PDZ domains facilitate protein-protein interactions by binding to the cytoplasmic C-terminus of transmembrane proteins, and PDZ-containing proteins mediate cell signaling and the organization of protein complexes. The encoded protein binds to phosphatidylinositol 4, 5-bisphosphate (PIP2) and plays a role in nuclear PIP2 organization and cell division. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. Read-through transcription also exists between this gene and the upstream FKBP1A (FK506 binding protein 1A, 12kDa) gene, as represented in GeneID:100528031. [provided by RefSeq, Sep 2011]
The Alternative Names of target: SDCBP2,SITAC,SITAC18,ST-2,ST2,Sdcbp2,Similar to TACIP18 (SITAC),Syndecan-binding protein 2,Syntenin 2,Syntenin-2

Target products collectionGo to Syntenin 2/SDCBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7436-Ag-1/ GM-Tg-hg-IP7436-Ag-2 Human Syntenin 2/SDCBP2 protein Human
GM-Tg-rg-IP7436-Ag-1/ GM-Tg-rg-IP7436-Ag-2 Rat Syntenin 2/SDCBP2 protein Rat
GM-Tg-mg-IP7436-Ag-1/ GM-Tg-mg-IP7436-Ag-2 Mouse Syntenin 2/SDCBP2 protein Mouse
GM-Tg-cynog-IP7436-Ag-1/ GM-Tg-cynog-IP7436-Ag-2 Cynomolgus/Rhesus macaque Syntenin 2/SDCBP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7436-Ag-1/ GM-Tg-felg-IP7436-Ag-2 Feline Syntenin 2/SDCBP2 protein Feline
GM-Tg-cang-IP7436-Ag-1/ GM-Tg-cang-IP7436-Ag-2 Canine Syntenin 2/SDCBP2 protein Canine
GM-Tg-bovg-IP7436-Ag-1/ GM-Tg-bovg-IP7436-Ag-2 Bovine Syntenin 2/SDCBP2 protein Bovine
GM-Tg-equg-IP7436-Ag-1/ GM-Tg-equg-IP7436-Ag-2 Equine Syntenin 2/SDCBP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7436-Ag-1/ GM-Tg-hg-IP7436-Ag-2; GM-Tg-rg-IP7436-Ag-1/ GM-Tg-rg-IP7436-Ag-2;
GM-Tg-mg-IP7436-Ag-1/ GM-Tg-mg-IP7436-Ag-2; GM-Tg-cynog-IP7436-Ag-1/ GM-Tg-cynog-IP7436-Ag-2;
GM-Tg-felg-IP7436-Ag-1/ GM-Tg-felg-IP7436-Ag-2; GM-Tg-cang-IP7436-Ag-1/ GM-Tg-cang-IP7436-Ag-2;
GM-Tg-bovg-IP7436-Ag-1/ GM-Tg-bovg-IP7436-Ag-2; GM-Tg-equg-IP7436-Ag-1/ GM-Tg-equg-IP7436-Ag-2
Products Name Syntenin 2/SDCBP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Syntenin 2/SDCBP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntenin 2/SDCBP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.